Restructuring of domestic drug makers foreseeable
Published: 2007-06-08 07:00:00
Updated: 2007-06-08 07:00:00
Influenced by a free trade accord between Korea and the United States and a new public health insurance regulation, the so-called positive list system, a number of Korean drug makers are likely to accelerate their restructuring programs through mergers and acquisitions.
Samyang Corporation and...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
